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Abstract
THE RELATIONSHIP BETWEEN NEAT CONSUMPTICN AND THE
BIOIiCGICAI. DETERMINANTS OF CARDIOVASCULAR DISEASE RISK
by
Fred E. Kcllwitz, M.D.
Fasting blood samples were collected from 26 omnivore and 27 vege
tarian men (35-60 years of age), who were not taking any medications and
The following analyses were

by self-assessment were in good health.
done:

glucose (Glu), glycohemoglobin (HBA1), total serum cholesterol

(chole), high density lipoprotein-cholesterol (HDD, low density lipo
protein (LDL), very low density lipoprotein (VLDL), platelet factor four
(PF4), and beta-thromboglobulin (BTG).

In addition, the blood pressure

(BP) was determined,.
The systolic (pCO.OOl) and diastolic BP (p=G.016) were lower in tine
vegetarian subjects than in the omnivores.

The serum total cholesterol

levels were also lower in the vegetarian subjects compared to the omnivores (p<0.05).

There was no significant difference in Glu, HBA1, LDL,

VLDL, HDL, PF4, and BTG levels between the two groups.
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INTRODUCTION

The fact that coronary heart disease is a major health problem in
the United States is no longer in question.

The grim sad evidence of

athersclerosis, seen in the autopsies performed on U.S. combat casual
ties in Korea and Vietnam, revealed the presence of athersclerotic
lesions in coronary arteries of 70% of those formerly healthy, active
young men (with a mean age of 21.1 years).
severe occlusive lesions.^

About 40% had moderate to

Coronary heart disease is responsible for

550,000 deaths per year and more than all forms of cancer combined.
It has been estimated that there are in the U.S. 5,400,000 Ameri
cans with symptomatic heart disease, exclusive of a large number who
have not been diagnosed.

The dollar costs of this illness is approx

imately $60 billion per year directly and indrectly.

Males are at a

higher risk than females, however, recent findings show females are
closing the gap.

Increasing age, obesity, diabetes mellitus, inactiv

ity, and hypertension are also risk factors.
directly related to hyperlipidemia.

These diseases are usually

Genetics has a strong influence on

families who have a history of any of the aforementioned pathology.
These

diseases should lead to a screening of the children for plasma

levels of cholesterol, LDL, HDL cholesterol, and triglycerides.2

It

probably behooves a pediatrician to be the "watchman on the wall" for
future generations and to make a sincere effort to control the cardio
vascular diease death rate.
The threat of cardiovascular disease, and what may be done to alter
these impressive mortality statistics has scientists searching for
methods to make an early diagnosis.

If an early diagnosis can be made,
1

2
can anything be done to alter the present trend of morbidity and
mortality? With this question in mind, we chose to investigate whether
diet could be an important factor regarding the diagnosis and further
progression of the pathology.

REVIEW OF THE LITERATURE

Platelets (Anucleated Cells)
The progenitors of platelets are the megakaryocytes which usually
comprise a small portion (one per several hundred) of the marrow cells.
The megakaryocytes mature through the blast cell to the intermediate
stage, then to a mature megakaryocyte.

It is at this stage that a

percentage of the cells will release or shed platelets.

It is estimated

that one human maegakaryocyte can release several thousand platelets.^
A number of proteins apparently unique to platelets have been
identified (PF4, BTG, and a platelet derived smooth muscle growth fac
tor).

Some effects of these secretory proteins include stimulation of

smooth muscle cells, and cell proliferation, which may be important in
the repair of vessel injury,

Platelets have also been found to contain

other proteins that are present in plasma, that is, fibrinogen, factor
V, factor VIII, fibronectin, and factor XIII.

In most instances it is

not known whether these proteins are absorbed or imbibed from plasma by
mature platelets, or are synthesized de novo.

Being enucleate, the

platelet has only vestigial remains of protein synthetic apparatus,
which implies protein synthesis in the megakaryocyte.^
The average lifespan of platelets is ten days.

The younger plate

lets are more active than the mature ones, and will promote hemostasis
at the site where microvascularization leakage occurs.

The spleen

sequestrates approximately 30%, the liver 45%, the marrow and lymph 515% of the toal number of platelets.

Alcohol abuse can lead to

decreased platelets, and eventually to thrombocytopenia.

This condition

can also be acquired in the case of megaloblastic anemia, secondary to a
3
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deficiency of either B12 or folic acid.^'^
The platelet count may fall as low as 10,000, to be followed by a
rebound phenomenon, when the count may rise to 600,000 to 800,000 for 14 weeks of duration.

Thrombopoietin is a hormone that stimulates

platelet production in response to thrombocytopenic stress.
deficiency the platelets can be normal,

In iron

moderately elevated or

strikingly elevated, to a level of one to two million per cubic millimeter.

When this deficiency is corrected the platelet count returns to

normal within one to two weeks.

Hirsch and Dancie ^ reported the

development of thrombotic complications in 5 of 15 patients whose plate
let count was persistently high.
Platelet stimulation results in the activation of phosphorylases
that hydrolyze the membrane phospholipid molecule, with the liberation
of Arachidonic acid (AA).

The AA is converted mainly to thromboxane A2

(TXA2) in the platelets by the AA cascade.^

Platelet Secretions
There are two types of storage granules that are distinguishable in
the platelets.

These are the dense granules which are homogenous and

electron dense.

The alpha granules are heterogenous, differing from one

another and from the dense granules in size and shape.-1- Figure 1 will
show this clearly.
The alpha granules may include acid hydrolases containing
organelles, whose content when stimulated is extruded into the cell's
environment. This specific extrusion is called "platelet secretion."
Many of these substances have direct action on cells and on the

5

Figure 1:

The stages of maturation through to the release of the
platelet. In actuality the platelet is much smaller
than the meta megakaryocyte. As diagrammed, the plate
let is connected at the metamegakaryocyte via filamentous
threads which also provide a physical structural network
to stabilize the position of the platelet. The diagram
shows some activating substances of the platelet and
their products.
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A.
B.
C.
D.

Megakaryoblast
Promegakaryocyte
Megakaryocyte
Metamegakaryocyte

E. Metamegakaryocyte with attached platelet
F. Platelet (1-4 micra enlarged)
plasma membrane
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alpha granules
dense granules
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Ca
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platelets themselves and are converted to physiologically active sub
stances in the plasma or on the cell surface.

The result of "in vivo"

platelet activation may vary from a "simple" change in the structure of
platelet membrane to the complete release reaction.

Stimuli unable to

promote a complete release reaction may, however, be sufficient to
determine a partial activation resulting in the release of alpha gran
ules.^

Serotonin is absorbed and secreted by platelets,

In addition,

they contain substantial actomyosin and this release is promoted by

extracellular calcium ions that can enter intercellularly under the
influence of thrombin.

Once inside the cell, they cause the organelles

to contract.
It is important to know that some of the plasma protein analogs,
such as fibrinogen, come from the alpha granules.
probably not a product of the granules.

However, they are

Therefore, megakaryocytes or

platelets do not synthesize fibrinogen, but accumulate it by some un
known method.^

Platelet Factors 1, 2, 3, and 4
Although there are specific substances that will selectively stimu
late platelets, one experimental product is a cationophore A-23187.^
This, as well as other substances, will stimulate the secretory proces
ses of the alpha dense granules and a general platelet response,

There

is a change in shape, aggregation and AA liberation, Arachidonic is sub-

sequently oxidized to a platelet activating substance, TXA2.

Some

strong platelet aggregation inducers are ADP 8,9,10 collagen, epine
phrine, TXA2, and thrombin; however, these are dependent upon the avail-
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ability of calcium, therefore, calcium channel blockers are inhibitors
of platelet secretion to a limited degree.
Another secretory platelet factor is the platelet growth factor,
which is capable of stimulating the proliferation of smooth muscle
cells.

This is of great importance in the formation of atheromas.

Platelet factor 1 refers to coagulation factor V in the platelets.
Platelet factor 2 accelerates the clotting of fibrinogen by thrombin;
and these terms are no longer used.

Platelet factor 3 has a phospho

lipid like activity, and platelet factor 4 has an anti-heparin like
activity.

Phospholipids make up 76% of the total lipids and are approx

imately constituted as follows:

phophatidyl choline (which is a surfac

tant), phophatidyl ethanol amine and sphingomylin.
stitute 20%, the remaining 4% are lipoproteins.

Neutral lipids con
The lipids cement the

membranes and at the same time serve a biological function.^
There are two types of PF4; one protein is regular, or normal PF4,
and is a high affinity protein; the other is a low affinity PF4 (LA-PF4)
at times also referred to as platelet factor 3 (PF3).^'5
Some characteristics of PF4 are as follows:

it is a low molecular

weight protein, glycoprotein found in the alpha granules, released from
the platelets by releasing factor followed by stimulation and aggrega
tion by ADP, thrombin, and epinephrine.^^

Platelets in a quiescent

state have a convex surface with random indentations representing sites
of communications between channels on the surface, either connected or
are open canalicular systems to the exterior of the cell (Figure 1).
This system provides for the orderly access to the interior of the cell
for plasma-born substances, and the egress for products of the release
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reaction.

Two proteins, a high affinity PF4 and a low affinity PF4 are

secreted by the platelets.

The hydrolitic cleavage product of the

latter, produced by platelet proteases, is called beta thromboglobulin.
both PF4 and BTG bind heparin.

Their levels in circulating plasma are

regarded as a measure of platelet activation in vitro.

PF4 is a low

molecular weight protein that is immunologically specific for platelets.
and all experimental evidence suggests that most of the proteins are
stored in the alpha granules.-^
The dense granules contain the minerals and vitamins, namely Ca,
Mg, Zn, folic acid, ascorbic acid, and cyanocobalamine.

Platelets of

themselves do not produce serotonin, but store it as a smooth muscle
vasoconstrictor. Consequently, serotonin is absent in the plasma and
other cells.

There is no reliable method of measuring serotonin except

biopsy of the sites of production, namely brain cells and argentofil
cells of the small intestines.

Serotonin has not been found to be
important in hemostasis in humans, but may be so in other species. 7
The two types of platelet granules are known as storage granules.

The reference "dense granules" implies that they are homogeneous and
electron dense.

If there is a deficiency of these, it is called a

"storage pool deficiency," with the resultant impaired homeostasis.

The

alpha granules are heterogeneous and differ from one another an from the
dense granules both in size and shape.
cellular elements.

All platelets have complete

As mentioned earlier they are anucleated, therefore,

they do not have DNA.^

10
Functions of PF4 and LA-PF4
1.

PF4 shortens the cascade of thrombin acting on fibrinogen to

fibrin, thereby reducing the time for clot formation.

2.

In the presence of heparin PF4 will potentiate ADP induced

aggregation n vitro to induce precipitation of fibrinogen, which is
normally soluble in plasma.
3.

PF4 will non-enzymatically clot or precipitate soluble fibrin

ogen in plasma.

PF4 will neutralize certain fibrinogen breakdown

products; may be a potent and specific agent triggering platelet aggre
gation, thereby shortening the time for blood clotting.
4.

The levels of PF4 in plasma are 3-16 ng/ml.

the range of what is commonly accepted as normal.

These values are

French, et al

, as a

result of their studies of thrombospondin BTG and PF4, suggest 34 ng/ml
for BTG and 6.1 ng/ml for PF4.

PF4 binds very tightly to heparin to

neutralize its anticoagulation activity.

LA-PF4 binds to low affinity

heparin, and is immunologically identical with BTG.
5.

LA-PF4 is acted upon in the circulation to convert to BTG by

splitting off the tetrapeptide from the end terminal of LA-PF4. 8
6.

Both LA-PF4 and PF4 are secreted simultaneously and have anti-

heparin effect.

Then the LA-PF4 is converted to BTG in the plasma.

The

PF4 is cleared more rapidly due to the substance adhering immediately to
the endothelial cell surface, whereas BTG, a derivative of LA-PF4 with
low heparin inhibiting effect, remains in the plasma longer. 8,12
Beta Thromboglobulin (BTG)
The name was given because it migrates in cellulose acetate in the
beta-globulin region.

The complete primary structure of human BTG is
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known and consists of 81 amino acids, with a molecular weight of 8,851.
The amino-acid sequence of BTG shows a marked homology to PF4 in that 42
of their residues are identical. 8
and BTG are four amino acids.

The only difference between LA-PF4

Experimental evidence suggests that La-

PF4 is originally secreted by the platelets during the platelet release
reaction, and subsequently converted to BTG by a heat-labile platelet
derived neutral protease or by plasmin.5

Plasmin, fibrinolysin, or

neutral protease split off a tetrapeptide from the end terminal of LAPF4, to yield BTG. 8 Some researchers feel that BTG binds to endothelial
cells and thereby inhibits production of prostacyclin formation.-^ BTG,
LA-PF4, and PF4 are immunologically specific for platelets, since they
do not occur in any other cells or tissues.

In platelet free plasma

levels are 500 times less than in platelet rich plasma,

This is the

basis for the test to measure their quantity in circulating blood as an
indicator for thrombogenesis.-^
One of the most crucial steps in the preparation of PF4 and BTG
tests is to make a careful preparation of the specimen by avoiding any
leakage of the coagulating proteins into the platelet free preparation.
Apparently the half-life of PF4 is so short that is cannot be measured
according to Daws^ and others.-1-5
be 100 minutes.

The half-life of BTG is estimated to

Other researchers^ find the half-life of these pro

ducts to be divided into two periods; namely, an inital rapid loss.
followed by a slower loss.
BTG may act locally at high concentration to favor platelet
aggregation by inhibiting PGI2 production.

The binding sites of BTG ,are

specific and will not accept PF4 on their sites.

LA-PF4 and LA-BTG
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accordingly regulate

although they do not have similar biological

effects.-^
BTG and PF4 acting in concert, yet independent of one another, are
involved in thrombin formation.

Forbes-^ in his experiment, measuring

the levels of BTG and PF4 in patients with transient ischemic attacks
(TIA) has shown that both these levels continue to remain high as long
as two months after an attack.

This is in agreement with the results of

Fisher^, Stewart-^, and it has been concluded that the highest values
carried a poor prognosis.

The results of these authors are completely

opposite to those of de Boer, et al^, who in 1982 reported no change in
BTG, PF4 plasma levels within 48 hours of a stroke.

A plausible explan

ation of the difference between these authors is offered by O'Brien and
Etherington^, who suggest measuring intra platelet levels of PF4 and
BTG to yield more reliable information.

The plasma level of any one

moment will depend upon the balance between the rate of release of the
protein from the platelets and the rate of its removal from the blood.
which is fast, the half lives of PF4 and BTG being about 20 minutes and
100 minutes respectively.^^
Fabris^ has shown a high specificity for PF4, BTG to antiplatelet
drug therapy.

When patients used combinations of dipyramidole (anti

platelet aggregator) with aspirin there was no effect on PF4 or BTG
levels; both remained at pathological levels.
patient with coronary artery disease.

This is also true for the

Either dipyridamole or aspirin

alone are effectivelyincreased cardiovascular morbidity and mortality has been estab
lished to be higher among smokers than among non-smokers.

Previous data
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has shown normal individuals could prevent an incrase in PF4, BTG levels
if the individual took aspirin prior to smoking.

The study of Davis, et

al^, was of men who were habitual smokers and who had coronary artery
disease.

Their data indicated that smoking stimulated platelet aggre

gate formation and the release of the content of alpha granules were
unaffected by the previous administration of aspirin.

Distribution and Function of Lipoproteins and Aprooroteins
In the previous pages of this thesis we have referred to the var
ious lipoproteins, and the accompanying diagram (Figure 2) will explain
the relationship of the lipoproteins to the apoproteins.

This relation

ship is important for futher understanding of the cardiovascular risk
factors and the cardiovascular protective factors.

Factors HDL, LDL
While we speak in generalities about HDL and LDL, we must be aware
that there are subfractions.
fractions:

To illustrate HDL, there are three sub-

HDL-1, HDL-2, HDL-3.

HLD-2 is a beneficial subfraction for

human beings, and may be raised with exercise and dietary intervention.
The LDL fraction has been divided into LDL1 and LDL2.

In this

thesis I shall consider both LDLi and LDL2 as LDL and avoid mentioning
the subfractions.
Analysis for possible correlations between HDL and total choles
terol and other lipids and lipoprotein fractions demonstrate a moderat
ely strong negative correlation between HDL cholesterol and triglyc
erides which was consistent when measured in the general population,

14

Figure 2:

Summary of percentage distribution of lipids in the
human plasma. Adapted from Kwiterovich (2)
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Table 1:

Composition and Function of Human Lipoproteins

Apoprotein

Lipoprotein

Function

Apo A-l

Chylomicron, HDL TGC

for enzyme
lecithin,
cholesterol
acyltransferace
(LCAT)

Apo B-48 associated with

Chylomicron

transports fat
out of
intestinal cell

Apo Br-100 associated with

VLDL, LDL

Uptake of
cholesterol
rich LDL

Apo C-II associated with

VLDL, HDL

cofactor for
lipoprotein
lipase

Apo D

HDL

associated with
cholesterol
esters transfer
complex

Chylomicron & remnants

responsible for
HDL, VLDL uptake
of chylomicrons
by liver

Apo E

associated with

associated with

associated with
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except for females.

There are indications that increased serum choles

terol is the most important risk factor before the age of 50 years.
Triglycerides have small negative correlation with LDL, except in fe
males, and a moderate correlation with total cholesterol.

As was expec

ted, there was a strong correlation between LDL and total cholesterol.
Statistical analysis indicates that HDL and LDL cholesterol were inde
pendent and significant factors in coronary heart disease prevalence.
Because the inverse correlation between HDL, cholesterol and triglyc
eride levels, the role of triglycerides as an independent risk-factor
was not found to be signficant on multiverate analysis, except for
females.

OO

Freinkel^ states that weight loss, nicotinic acid and clofibrate
treatment lower VLDL and raise HDL levels. He states that diets high in
carbohydrates have the opposite effect on the levels of these two lipo
proteins.

In all these conditions, reciprocity appears to be present

between HDL and VLDL levels.

The only known exception to this general

ization are alcohol consumption and estrogen treatment, both of which
raise HDL and VLDL levels.

HDL
With a balanced diet, the mean synthetic rate for HDL protein was
8.5 mg/kg/day.^

Carbohydrate feedings resulted in a smaller mean

particle size, a lower ratio of apoA-1 to apoA-II in HDL, and a larger
portion of the total plasma HDL present in the smaller HDL-3 fraction.
In all of these repects, reciprocal changes were seen with nicotinic
acid treatment.

Both perturbations had very little or no effect on the

18
synthetic rate of HDL protin.
HDL catabolic pathway.

Major effects, however, were seen on the

Thus the high-carbohydrate diet significantly

increased the rate of HDL protin catabolism from the plasma compartment
(and lowered plasma HDL level), whereas nicotinic acid had reciprocal
effects.-^Triglycerides rise during a low fat diet because carbo
hydrates induce the synthesis of VLDL triglycerides,

however, the claim

has been made that the rise ini triglyceride concentration accompanying
a high carbohydrate diet abates when such a diet is prolonged.
Some reflections on HDL are as follows:

lowering of HDL can be

caused by reduced levels of the enzyme lecithin cholesterol acyltrans
ferase (LCAT) or reduced levels of apoA-1 and HDL levels can be very
low, a finding that is associated with premature atherosclerosis.
Shephard, et al,25 who studied a tenfold increase of the P/S ratio
(from 0.4-4.0) in his subjects showed a decrease in HDL cholesterol and
apo protein A-l.

This has been confirmed in other studies^ of infants

and formula manipulations to affect the outcome. From this and several

other reports 2,25 some consistency is emerging with regards to the
effect that diets high in polyunsaturated fat (P/S ratio from 1.6 to
4.0) are associated with lower concentrations of apoprotein A-l and HDL
cholesterol than a low intake of polyunsaturated fats (with a P/S ratio
from 0.25-0.45).

It also appears, however, that a wide range of dietary

cholesterol (20-5,000 mg/dl) has little effect on HDL cholesterol and
apo protein A-l, although LDL and total cholesterol rose.26'27

The Oslo

Study26 and Multiple Risk Factor Intervention Trial2^ have been cited as

evidence that polyunsaturated fat does not alter HDL cholesterol concen
tration in humans.

In neither study did the P/S ratio exceed 1.0, and

19

since the populations were free living, even this ratio cannot be docu
mented.

The apparent lack of reduction in HDL concentration might be

attributable to the populations studied.

LDL Cholesterol
Earlier in the thesis it was stated that we would consider LDL as
one entity; however, there are two LDL cholesterols.

It is a point of

interest that there is a normal LDL cholesterol and what might be con
sidered an abnormal LDL cholesterol, the latter having as its characn

teristics a low molecular weight and abnormal chemical composition.^

It

is this latter one that is elevated with a typer apoB, and is character
istic of those people with an endogenous hypotriglyceridemia.

This is

associated with the atherosclerosis and those who would appear at greater risk for coronary artery disease.

Biological and Hematological Variables in Vegetarians
Some literature states that vegetarians have lower serum choles
terol than non-vegetarians, and a lower prevalence of ischemic heart
disease than the general population. Earlier studies (West and Hays,
1968; Sacks, et al, 1975; Burslem, et al, 1978) confirm previous observvations that vegetarians have a lower blood cholesterol than non-vege
tarians.

Although the HLD cholesterol was the same for both groups, the

vegetarians had a higher HDL as a percentage of the total cholesterol.
This was in accord with Gears'^ report.

Some variables to consider are

the vegetarians' higher fiber intake, difference in life styles, general
interest in healthful living and family, and often non-smokers.

Vege-
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tarians are usually leaner than non-vegetarians, yet in subjects that
were matched this did not account for a difference in the lipid level
which could be demonstrated in pairs of subjects matched for weight.
The study done by GearJU stated that the difference in cholesterol
concentration might be because of a difference in saturated fat intake.
rather than because vegetarians have a higher intake of dietary fiber.
Vegetarians with a saturated and a monounsaturated intake of over 50
gm/day had a mean plasma cholesterol concentration of 239 mg ml, which
is similar to that of non-vegetarians.

No relationship was apparent

between cholesterol and dietary fiber.

The difference between blood

glucose and high density lipoproteins (HDL) expressed as a percentage of
total cholesterol was small but consistent and statistically signifi
cant.*^^
In the above study, the ratio of cholesterol to HDL in a vegetarian
was 3.26 and that of the non-vegetarian was 3.86; small but consistent,
and statistically significant (the percentage of HDL in a vegetarian was
30.6 and percentage of HDL in a non-vegetarian was 25.2).

It is inter

esting to note that he reported identical HDL values for both vege
tarians and non-vegetarians.-^

Burr, et al*^ in his report, found that

85 vegetarians showed an average of lower cholesterol and a higher HDL
than 214 non-vegetarians.

The Burr, et al,^ value of percentage of HDL

with vegetarian was 24.35 and non-vegetarians were 19.28.

The values

represent men of less than 60 years of age.^***
Blood Pressure in Vegetarians and Omnivores
The mean systolic and diastolic pressure showed no consistent or
significant differences between vegetarian and nonr-vegetariaru^l

This
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is in contrast with some of the findings of Sacks, et al^ (1975) and
Armstrong, et al*^ (1979), who reported lower systolic and diastolic
pressures in vegetarians, although the results were not large.
A recent study done in London on various disorders among omnivores
and vegetarians showed a "significant downward trend in disease prevarlence with the adoption of vegetarian-vegan diet."

Angina pectoris was

diagnosed in omnivores in the fifth and sixth decades of life, and in
the lifelong vegetarians not until the seventh and eighth decades of
life.34

PURPOSE
Blood pressure, glycohemoglobin, total cholesterol, HDL choles
terol, cholesterol HDL ratio, LDL, Platelet Factor 4, and Beta Thromboglobulin were compared between a group of vegetarians and omnivores.
The gross pathological anatomy of myocardial infarct has been well
appreciated for many years.

The micro-pathological anatomy is still in

the unfolding stage and for this reason the study of PF4 and BTG was
chosen.

We limited our patients to vegetarian and omnivore males whose

present ages were between 35 and 60 years old.

Our source of patients

were those who had previously been in the Adventist Health Study of
1978.

There were a total of 312 names in this previous study, of which

we randomly selected 27 vegetarians and 26 omnivores from the list.

All

of those who consented and met the criteria were accepted for the study.
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METHODS

I personally telephoned each participant and talked directly with
him, discussed the tests that were planned and of what value they would
be to him regarding his health.

An option was offered to the patient,

to either mail the results directly to him, or to the physician of his
choosing.

We made no attempt to discuss the results, other than to

point out those results which were out of the normal ranges.

We mailed

each patient his results and made ourselves available for any further
inquiry from their physician.

This was done to avoid any potential of

malpractice implications to either the University or team members.

At

the outset of the telephone conversations we did a survey concerning
their self-appraisal of their own health.

That is, we questioned them

as to whether they were, generally speaking, in good health,

We also

aksed if they had any known diease for which they were being treated.

All of our candidates met the above mentioned standards.

In addition,

none were taking medications on a regular basis.
The patients were mailed a consent form and brought it with them
the morning of the phlebotomy.

Included in the mailing were instruc-

tions to the participant for the drawing of their fasting blood,

Each

blood sample had a minimum of a 12-hour fasting state.
The majority of patients were physicians, dentists, or allied
health professionals who were assumed Seventh-day Adventists living
within a radius of 15 miles from the Loma Linda University Graduate
School, Department of Nutrition,

We assumed that none of these volun-

teers were using tobacco in any form, since it is prohibited by the
Articles of Faith for Seventh-day Adventists.
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Each candidate was allowed to be seated for a few minutes in order
to relax prior to measuring his blood pressure (BP) in each arm.

The

antecubital fossa was prepared in a routine manner for the phlebotomy.
The BP cuff was kept in place and maintained at a level between the
systolic and diastolic levels? this was done to facilitate the ease of
phlebotomy.

Two separate 20cc disposable syringes were used per pa

tient, and each syringe had blood drawn up to the 15 ml mark.

The #20

gauge disposable needle was left in the vein during the syringe changes.
Prior to taking blood into the second syringe, we allowed a free flow of
blood for approximately 3-5 cc before connecting the syringe.

This was

done to minimize any platelet disturbance or extraneous clotting mater
ial from contaminating the sample.

The first syringe of blood was

promptly put into respective tubes with anticoagulant material.

The

second syringe of blood was put into separately labelled PF4, BTG tubes
for radioimmunoassay (RIA).

The blood was gently allowed to run down

the side of the tube to limit any physical disturbances to the cells.
When filled, the tube was put into an ice bath until a sufficient number
of tubes were collected to continue the next step in the procedure,
which was to centrifuge the specimens at a precalculated speed of 3,200
rpm in a temperature controlled centrifuge at 2-4 degrees Centigrade for
30 minutes.
The tests performed for glucose, glycohemoglobin, total choles
terol, and high density lipid analysis were done utilizing Sigma Chemi
cal Company laboratory kits.

The procedures outlined in the kits were

followed very carefully to ensure good laboratory results.
It was physically impossible to do all of the lab testing in a

25

single day, therefore, the plasma was frozen when not in use, and stored
to be available as needed.

Thawing and refreezing was avoided and the

samples were used as needed for that day.

Several of the fasting blood

sugars were run on whole blood and some on plasma.

The LDL and VLDL

values were done by the Faculty Medical Laboratoy.
The PF4 RIA diagnostic kit was supplied by Abbott Diagnostic
Laboratories.
The Amersham Corporation has available a thrombotect kit for the
BTG, which was used to measure BTG.
procedures.

Both the PF4 and the BTG are RIA

RESULTS
Table 1 shows a significant difference in p values in both the
systolic and diastolic BP of vegetarians vs. omnivores.
results show the vegetarians are significantly lower.

The obvious

When we recorded

the BP of our subjects, we took the pressure in each arm and then
recorded the average of the two systolic readings and the average of the
diastolic readings.
Tables 2 and 3 dealing with glucose in the fasting state and the
glycohemoglobin show no statistical difference between the vegetarian
and the omnivore.

This is somewhat unexpected since other literature

shows significant differences between these two groups, largely as the
result of the vegetarian having a higher complex carbohydrate diet and
with its associated glucose lowering effect.'^,•^'^
The lipid profile, as seen in Table 4, does show significant dif
ference in the cholesterol and the cholesterol high density lipid ratio
betwen the vegetarians, who have lower levels, and the omnivores, who in
turn have higher levels.

The HDL and LDL showed no significant dif

ference.
However, in Table 5 the p value on the LDL studied showed 0.07,
which almost reached a value of significance between the vegetarian and
the omnivore groups.
Table 6, the last part of this study, involved PF4 and BTG.

These

showed no significant difference between either vegetarian or omnivore.
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Table 2:

Means of right and left arms systolic and diastolic blood
pressure of vegetarians (23) and omnivores (25). Five
readings are missing separate variance estimates (itmHg + S.E.)

Systolic BP

Diastolic BP

Vegetarians (23)

106.2 +2.5

74.2 ± 2.2

Cmnivores (25)

121.7 ± 3.1

83.5 ± 2.3

Recorded readings of patients in seated and related position.
pKO.Ol vegetarians vs. omnivores
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Table 3:

Fasting blood sugar values of vegetarians and annivores.
Fasting levels are an overnight fast of 12 hours (mg/dl +
S.E.)
Fasting
Blood Sugar

P Values

Vegetarians (27)

95.8 ± 6.2

N.S.

Crnnivores (26)

98.2 ± 3.4

N.S.

N.S. - Not Significant
Normal fasting glucose levels 60-110 mg/dl
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Table 4:

Determination of glycohemoglobin in vegetarians and omnivores
(mg/dl + S.E.)

Glycohemoglobin

P Values

Vegetarians (27)

6,5 + 0.52

N.S.

Omnivores (26)

6.2 ± 0.42

N.S.

N.S. - Not Significant
Normal Glucohemoglobin levels 4.0 - 9.6 mg/dl
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Table 5:

Overnight 12-hour fasting levels of plasma cholesterol and
HDL of vegetarians and omnivores (mg/dl + S.E.)

Vegetarians

Cholesterol

HDL-Chol

200.4 ± 8.8*

47.3 ± 2.6

4.5 ± 0.34*

235.3 ± 11.3

43.7 ± 2.9

5.9 ± 0.44

Cholesterol/HLD-Chol

(27)
Omnivores
(26)

* p<0.05 canparing vegetarian with ormivore

Normal cholesterol levels 125-220 md/dl
Normal cholesterol/HDL levels (male) <4.97 md/dl
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Table 6:

Overnight 12-hour fasting levels of plasma LDL for vegetarians
and omnivores (mg/dl + S.E.)
LDL

Vegetarians (16)

144.6 ± 7.4

Qnnivores (12)

181.7 ± 18.1 N.S.

N.S.

Normal LDL levels 66-178 md/dl
HDL and LDL were performed by Lora Linda University Faculty Medical
Lab.
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Table 7:

Radioinmunoassays for PF4, BTG on vegetarians and annivores.

PF4

BTG

Vegetarians (27)

38.2

±

6.3

67.8 ± 13.0 N.S.

Qnnivores (26)

38.1

+

6.8

87.1 ± 17.1 N.S.

DISCUSSION

The findings in this study concerning the BP were consistent with a
great many other authors, as stated earlier in this thesis.

There

was a significant decrease in both systolic and diastolic values when
the vegetarian is compared to the omnivore.

Yet, Burr, et al,31 who in

1981, while studying plasma cholesterol and BP in vegetarians, found no
consistent or significant difference between vegetarians and non-vege
tarians when measuring the mean systolic and diastolic pressures.

These

findings may be related to some of the health habits of some Seventh-day
Adventist vegetarians, in that they do not drink any caffeine, or very
limited amounts, whereas the study of Burr, et al,3^ may have not had
this variable controlled.
Concerning glucose and glycohemoglobin, it was anticipated that
both of these values would be reduced.^'33

One of the reasons, maybe,

that there was no difference between vegetarians and omnivores might be
due to no known history of diabetes in either one of the groups studied.
The literature is replete with references for the treatment of both type
I and type II diabetes by increasing the complex carbohydrates and
lowering fat.^'32,35

This makes a significant change, lowering glucose

and glycohemoglobin.

This is one of the goals which the American Dia

betic Association strongly endorses.

The men stuied were of above

average intelligence, and for the most part were health professionals;
they may have been aware of the value of complex carbohydrates in their
diet and consumed more in their diets than non-professionals.
Table 3 showed both cholesterol and cholesterol/HDL ratio indica
ting significant differences between the vegetarian and omnivore.
33

Earl-
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ier studies by West, Hayes, and Gear also show significant reduction in
these values among vegetarians, compared to omnivores.
The LDL and the VLDL values showed no significant differences.
However, as noted earlier, the p value for the LDL was .07 and almost of
significant value.

Even though the lab results are in a normal range.

the vegetarians in this study are somewhat at risk if we would assume
that 100 mg/dl or more would put a person at risk.
The RIA as shown in Table 6 showed no significant difference be
tween the PF4 and BTG of the two groups studied.
13 ng/ml and BTG 50 ng/ml.

PF4 normal values are

Perhaps there is not any significant dif

ference in either PF4 or BTG, in what appears to be normal health
patients, and any differences may be relevant when cholesterol levels
are higher than what these subjects have.
There was no significant correlation between the following:
total cholesterol and PF4
total cholesterol with BTG
HDL with PF4
HDL with BTG
systolic BP with PF4
diastolic BP with PF4
systolic BP with BTG
diastolic BP with BTG
PF4 with BTG

systolic BP with cholesterol
diastolic BP with cholesterol
systolic BP with HDL
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diastolic BP with HDL
systolic BP with glucose
diastolic BP with glucose
systolic BP with HBA1 or
glychoheinoglobin or diastolic BP with HBA1.

CONCLUSIONS

If this experiment were repeated again, I now am aware of a number
of variables that should be controlled

in a future study.

Some of the

variables are to try to make an estimate of the number of large and
small platelets, evaluate if there is a possible iron or vitamin B12
deficiency which could affect the platelet count, and any recent pre
vious platelet count to evaluate with the present platelet count, there
by evaluating if rebound phenomena are present.

Some of the anti

platelet factors that were not considered in this study were whether or
not the patient had ingested aspirin within five days prior to his
phlebotomy, what amount of fish the omnivore is eating (involving omega3 fatty acid ingestion, thus influencing platelets), what individual
donor thrombopoiesis accountability, the matter of platelet separation
(the force of centrifugation) and the specific gravity of the centrifuge
media, the variation in platelet concentration affecting platelet meta
bolism due to thrombocytopenia and/or thrombocytoses, mainain the syr
inges in a cool temperature and be certain that the assistances minimize
physicaol disturbance to the samples.
risk factor in my study.

Smoking has been overlooked as a

I would also wish to know how much exercise

that person does on a regular basis, and to what extent he drinks
coffee.

Frederickson's classification would have organized the group

ings of those patients who had an elevated cholesterol.

If we would

have had their classifications, we would have an approximate idea of the
concentrations of HDL, VLDL, and LDL.
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SUMMARY
The vegetarians (26) versus omnivores (27) showed significant de
crease in systolic BPf diastolic BP, chole, RHDL while the LDL, Glu,
HDL, VLDL, PF4, and BTG, as well as correlation between these values,
were not significant by statisticaly analysis.
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APPENDIX A
Vegetarian

I DENT
1

BLD PRESS
138/86

2

GLUC

Hb A1C

CHOLES
HDL

LDL
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Appendix A Continued
Omnivore

WENT

BLD PRESS

1
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Hb AlC
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HDL

CHOLES
HDL

LDL
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9
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APPENDIX B
Health Questionnaire
Study #
Part A

1.

Today's Date:

/
mo

2.

Date of Birth

/
mo
]

/
day

/
yr

3.

Sex:

4.

Has a doctor ever told you that you had any of these conditions?
Mark "yes" only for conditions diagnosed by a doctor, even if the
condition is no longer present. Be sure to mark "no" for conditions
you have never had.

5.

Male [

/
/
day yr

Female [

]

4a.

Heart attack or coronary (myocardial infarction)

No [ ]
Yes [ 3

4b.

Stroke or apoplexy

No [ 3
Yes [ 3

4c.

High blood pressure

No [ 3
Yes [ 3

4d.

Diabetes

No [ 3
Yes [ 3

4e.

Cancer or leukemia

No [ 3
Yes [ 3

Please list the prescription drugs you have taken in the last 30
days: (Please print)

43

Health Questionnaire Continued

44

6.

Please list the non-prescription drugs (e.g • r aspirin, Bufferin,
Tylenol, Contact) that you have taken in the last 30 days (please
print):

7.

What is your best estimate of your present weight and height in
normal indoor clothing without shoes?
a.

Current height

ft

b.

Current weight

lbs

in.
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Lorna Linda University

Consent Form for Diet and Health Study

, hereby agree to participate in this study

I,

on the relationship between dietary factors and cardiovascular disease risk.
Specifically we will be measuring blood pressure, blood cholesterol and other
blood fats, blood sugar and blood clotting.
As part of this study, I have agreed to complete a questionnaire about
my diet and

lifestyle and

Faculty Medical

to spend

Offices located

anything after 10 p.m.

approximately one

in Loma Linda.

hour or less at the

I have agreed

to not eat

the evening before my visit to Loma Linda, however
Furthermore,

no limit for plain water.

I will not eat breakfast on the day

of my visit to Loma Linda.
During my visit to Loma Linda,
blood will be drawn.
samples

will

cholesterol
Each

be

I have been told that two samples of

The blood will be drawn by a physician.

used

to

detect

diabetes,

measure

the

amount

The blood
of

blood

and other substances related to the clotting action of my blood.

sample will

consist of approximately three tablespoons of blood

(i.e.,

It is possible that a small amount of

approximately 30 cubic centimeters).

blood may temporarily accumulate at the site on my arm where the blood is
drawn.
bruise.
following

This may cause the site to become slightly discolored like a small
(This

is

only

blood drawing.)

a

temporary

condition

and

is a

common

condition

My blood pressure will also be taken during my

visit to Loma Linda.

45
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have

been

chemistries
may

told

and

alert me

that

blood

to

I

can

■

46

flfio

Loma Linda University
I

C'/j

request

that

the presence of diabetes,

• '

my

pressure be forwarded

School of Health
Department of Nutrition
Loma Linda, California 92354
714/824-4598

study

on

blood

These study results

to me.
high

results

blood

pressure,

and high

blood cholesterol.
I have been told that all the information collected in this study will be
kept strictly confidential.

My name will never be associated with any of the

data released from this study.
While
that

the

risks

emergency

during

my

824-4634,

Loma

involved

in

this

treatment

is

available

Linda

visit.

I

Patient Representative,

study are minimal,
should

should

a

health

contact

Glenn

I have been told
problem

develope

Sharmann

(714)

for information and the required forms.

I

also have been told that I am free to withdraw from this study at any time.
I may call Dr.

Blankenship at (714) 824-4300,

ext.

7172 if I have questions

about this study.
After

signing

this

form,

I

will

receive

a

copy.

I have read

the

contents of this consent form and questions regarding this study have been
answered to my satisfaction.

I hereby give voluntary consent to participate

in this study.

Signature of Subject

Date

Signature of Witness

Date

Signature of Investigator

Date

